Incidence of acute kidney injury post cardiac surgery: a comparison of the AKIN and KDIGO criteria.


Journal

Brazilian journal of anesthesiology (Elsevier)
ISSN: 2352-2291
Titre abrégé: Braz J Anesthesiol
Pays: Brazil
ID NLM: 101624623

Informations de publication

Date de publication:
Historique:
received: 12 07 2019
accepted: 14 11 2020
entrez: 19 9 2021
pubmed: 20 9 2021
medline: 26 10 2021
Statut: ppublish

Résumé

Data on urine output have not been routinely presented to define cardiac surgery-related acute kidney injury (AKI). We evaluated the incidence of AKI after cardiac surgery based on the AKIN and KDIGO criteria (considering serum creatinine concentration and urine output in the first 72 hours postoperatively) and compared the performance of the 2 criteria for AKI staging. This was a prospective cohort study of adult patients undergoing coronary artery bypass grafting (CABG), valve replacement, or CABG + valve replacement between October 2017 and April 2018 at a single institution. Patients were excluded if baseline creatinine concentration (measured within 7 days before surgery) was ≥ 2.5 mg.dL A total of 198 patients were included. AKI occurred in 83.8% by AKIN and in 82.8% by KDIGO, when using both urine output and serum creatinine concentration as defining criteria. Using serum creatinine concentration alone, the incidence of AKI fell to 27.3% by AKIN and to 24.7% by KDIGO. A kappa coefficient of 0.98 was obtained between the AKIN and KDIGO criteria. Almost perfect agreement was found between AKIN and KDIGO. AKI may be underdiagnosed after cardiac surgery if serum creatinine concentration is used as the only defining criterion. Our findings underscore the fundamental importance of using the urine output criterion in the assessment of patients at risk for AKI.

Sections du résumé

BACKGROUND AND OBJECTIVES
Data on urine output have not been routinely presented to define cardiac surgery-related acute kidney injury (AKI). We evaluated the incidence of AKI after cardiac surgery based on the AKIN and KDIGO criteria (considering serum creatinine concentration and urine output in the first 72 hours postoperatively) and compared the performance of the 2 criteria for AKI staging.
METHODS
This was a prospective cohort study of adult patients undergoing coronary artery bypass grafting (CABG), valve replacement, or CABG + valve replacement between October 2017 and April 2018 at a single institution. Patients were excluded if baseline creatinine concentration (measured within 7 days before surgery) was ≥ 2.5 mg.dL
RESULTS
A total of 198 patients were included. AKI occurred in 83.8% by AKIN and in 82.8% by KDIGO, when using both urine output and serum creatinine concentration as defining criteria. Using serum creatinine concentration alone, the incidence of AKI fell to 27.3% by AKIN and to 24.7% by KDIGO. A kappa coefficient of 0.98 was obtained between the AKIN and KDIGO criteria.
CONCLUSIONS
Almost perfect agreement was found between AKIN and KDIGO. AKI may be underdiagnosed after cardiac surgery if serum creatinine concentration is used as the only defining criterion. Our findings underscore the fundamental importance of using the urine output criterion in the assessment of patients at risk for AKI.

Identifiants

pubmed: 34537122
pii: S0104-0014(21)00035-X
doi: 10.1016/j.bjane.2021.02.016
pmc: PMC9373082
pii:
doi:

Substances chimiques

Creatinine AYI8EX34EU

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

511-516

Informations de copyright

Copyright © 2021 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. All rights reserved.

Références

Biochem Med (Zagreb). 2012;22(3):276-82
pubmed: 23092060
Rev Bras Ter Intensiva. 2009 Mar;21(1):25-31
pubmed: 25303125
Crit Care Med. 2014 Sep;42(9):2069-74
pubmed: 24810529
BMC Nephrol. 2018 Jun 25;19(1):149
pubmed: 29940876
PLoS One. 2017 Jul 10;12(7):e0181158
pubmed: 28700753
Ann Thorac Surg. 2010 Dec;90(6):1939-43
pubmed: 21095340
Methodist Debakey Cardiovasc J. 2012 Jul-Sep;8(3):31-6
pubmed: 23227284
Cardiorenal Med. 2013 Oct;3(3):178-199
pubmed: 24454314
J Am Soc Nephrol. 2005 Jan;16(1):162-8
pubmed: 15563569
Anaesth Crit Care Pain Med. 2016 Apr;35(2):151-65
pubmed: 27235292
J Am Soc Nephrol. 2015 Sep;26(9):2231-8
pubmed: 25568178
Ann Thorac Surg. 2016 Nov;102(5):1482-1489
pubmed: 27319985
J Thorac Cardiovasc Surg. 2018 Jun;155(6):2455-2463.e5
pubmed: 29548590
Nephron. 2018;140(2):105-110
pubmed: 29945154
Arq Bras Cardiol. 2013 Jul;101(1):18-25
pubmed: 23752340
Cardiorenal Med. 2013 Apr;3(1):26-37
pubmed: 23801998
J Cardiothorac Vasc Anesth. 2017 Jun;31(3):827-836
pubmed: 27856153
Ann Thorac Surg. 2011 Oct;92(4):1539-47
pubmed: 21872837
BMC Nephrol. 2017 Mar 16;18(1):93
pubmed: 28302078
Rev Bras Cir Cardiovasc. 2014 Jul-Sep;29(3):299-307
pubmed: 25372901
J Am Soc Nephrol. 2000 Jan;11(1):97-104
pubmed: 10616845
Crit Care. 2014 Jul 08;18(4):R144
pubmed: 25005361
Clin J Am Soc Nephrol. 2014 May;9(5):848-54
pubmed: 24578334

Auteurs

Tiago Furquim da Silva (TFD)

Sociedade de Anestesiologia (SANE), Porto Alegre, RS, Brazil. Electronic address: drtiagofurquim@gmail.com.

Kelly Regina da Cruz Silva (KRDC)

Instituto de Cardiologia, Fundação Universitária de Cardiologia (IC-FUC), Porto Alegre, RS, Brazil.

Crissiane Melo Nepomuceno (CM)

Instituto de Cardiologia, Fundação Universitária de Cardiologia (IC-FUC), Porto Alegre, RS, Brazil.

Cora Salles Maruri Corrêa (CSM)

Instituto de Cardiologia, Fundação Universitária de Cardiologia (IC-FUC), Porto Alegre, RS, Brazil.

João Pedro Mello Godoy (JPM)

Instituto de Cardiologia, Fundação Universitária de Cardiologia (IC-FUC), Porto Alegre, RS, Brazil.

Ari Tadeu Lírio Dos Santos (ATLD)

Sociedade de Anestesiologia (SANE), Porto Alegre, RS, Brazil.

Alessandra Sarturi Gheller (AS)

Sociedade de Anestesiologia (SANE), Porto Alegre, RS, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH